Steven Davidoff Solomon and Peter J. Henning write for The New York Times, August 1, 2014
Allergan has taken a well-worn route to fight off a takeover bid from Valeant Pharmaceuticals and William A. Ackman’s hedge fund, Pershing Square Capital Management: Sue them.